A detailed history of Wellington Management Group LLP transactions in Biogen Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 5,166,491 shares of BIIB stock, worth $898 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
5,166,491
Previous 5,120,142 0.91%
Holding current value
$898 Million
Previous $1.1 Billion 8.48%
% of portfolio
0.22%
Previous 0.2%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $8.83 Million - $11 Million
46,349 Added 0.91%
5,166,491 $1.2 Billion
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $1.09 Billion - $1.37 Billion
5,120,142 New
5,120,142 $1.1 Billion
Q4 2023

Feb 12, 2024

BUY
$222.59 - $267.94 $1.19 Billion - $1.43 Billion
5,324,396 New
5,324,396 $1.38 Billion
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $7.08 Million - $7.99 Million
27,951 Added 0.52%
5,374,310 $1.38 Billion
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $29.3 Million - $33.9 Million
-106,529 Reduced 1.95%
5,346,359 $1.52 Billion
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $10.7 Million - $12.2 Million
41,675 Added 0.77%
5,452,888 $1.52 Billion
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $69.6 Million - $84.5 Million
275,596 Added 5.37%
5,411,213 $1.5 Billion
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $224 Million - $309 Million
-1,151,108 Reduced 18.31%
5,135,617 $1.37 Billion
Q2 2022

Aug 15, 2022

BUY
$187.54 - $223.02 $6.98 Million - $8.3 Million
37,199 Added 0.6%
6,286,725 $1.28 Billion
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $12.6 Million - $15.9 Million
65,071 Added 1.05%
6,249,526 $1.32 Billion
Q4 2021

Feb 11, 2022

BUY
$223.92 - $287.77 $136 Million - $175 Million
606,735 Added 10.88%
6,184,455 $1.48 Billion
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $6.83 Million - $8.91 Million
-24,141 Reduced 0.43%
5,577,720 $1.58 Billion
Q2 2021

Aug 16, 2021

SELL
$259.0 - $414.71 $78 Million - $125 Million
-300,980 Reduced 5.1%
5,601,861 $1.94 Billion
Q1 2021

May 17, 2021

BUY
$242.95 - $284.63 $29.4 Million - $34.4 Million
120,868 Added 2.09%
5,902,841 $1.65 Billion
Q4 2020

Feb 12, 2021

BUY
$236.26 - $355.63 $218 Million - $329 Million
924,781 Added 19.04%
5,781,973 $1.42 Billion
Q3 2020

Nov 16, 2020

BUY
$264.77 - $305.71 $22.1 Million - $25.5 Million
83,432 Added 1.75%
4,857,192 $1.38 Billion
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $176 Million - $232 Million
678,521 Added 16.57%
4,773,760 $1.28 Billion
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $151 Million - $191 Million
-560,517 Reduced 12.04%
4,095,239 $1.3 Billion
Q4 2019

Feb 11, 2020

BUY
$220.06 - $304.07 $1.02 Billion - $1.42 Billion
4,655,756 New
4,655,756 $1.38 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.